Royal Bank of Canada Reaffirms Sector Perform Rating for Clorox (NYSE:CLX)

Clorox (NYSE:CLX)‘s stock had its “sector perform” rating reiterated by Royal Bank of Canada in a research report issued on Thursday,Benzinga reports. They currently have a $150.00 target price on the stock. Royal Bank of Canada’s target price suggests a potential downside of 6.21% from the stock’s current price.

CLX has been the subject of a number of other research reports. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Evercore ISI cut their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, Barclays reduced their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $156.07.

Clorox Stock Up 1.3 %

Shares of NYSE:CLX traded up $2.12 during trading hours on Thursday, reaching $159.93. The stock had a trading volume of 255,238 shares, compared to its average volume of 982,454. The stock has a market capitalization of $19.80 billion, a price-to-earnings ratio of 55.73, a P/E/G ratio of 2.92 and a beta of 0.42. The firm’s 50 day moving average is $163.15 and its 200-day moving average is $158.01. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 EPS. Research analysts predict that Clorox will post 6.87 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Clorox

A number of institutional investors have recently modified their holdings of CLX. Brooklyn Investment Group grew its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the period. Quarry LP lifted its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the last quarter. Finally, Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter worth about $32,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.